{{Rsnum
|rsid=4938723
|Gene=BTG4
|Chromosome=11
|position=111511840
|Orientation=plus
|GMAF=0.3076
|Gene_s=BTG4,MIR34B,MIR34C
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 12.4 | 43.4 | 44.2
| HCB | 12.4 | 43.1 | 44.5
| JPT | 8.8 | 41.6 | 49.6
| YRI | 8.2 | 37.4 | 54.4
| ASW | 3.5 | 52.6 | 43.9
| CHB | 12.4 | 43.1 | 44.5
| CHD | 7.3 | 38.5 | 54.1
| GIH | 6.9 | 38.6 | 54.5
| LWK | 10.0 | 40.9 | 49.1
| MEX | 1.7 | 39.7 | 58.6
| MKK | 7.1 | 46.2 | 46.8
| TSI | 14.7 | 53.9 | 31.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20309940
|Title=A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma
}}

{{PMID Auto
|PMID=23516510
|Title=Associations of pri-miR-34b/c and pre-miR-196a2 Polymorphisms and Their Multiplicative Interactions with Hepatitis B Virus Mutations with Hepatocellular Carcinoma Risk
|OA=1
}}

{{PMID Auto
|PMID=23526039
|Title=Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study
|OA=1
}}

{{PMID Auto
|PMID=23632240
|Title=Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma
}}

{{PMID Auto
|PMID=24065649
|Title=Single-nucleotide polymorphism of the pri-miR-34b/c gene is not associated with susceptibility to congenital heart disease in the Han Chinese population
}}

{{PMID Auto
|PMID=24063968
|Title=A causal role for circulating miR-34b in osteosarcoma
}}

{{PMID Auto
|PMID=24194751
|Title=Associations of miR-499 and miR-34b/c Polymorphisms with Susceptibility to Hepatocellular Carcinoma: An Evidence-Based Evaluation
|OA=1
}}

{{PMID Auto
|PMID=24337371
|Title=Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer
}}

{{PMID Auto
|PMID=23504554
|Title=Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
}}

{{PMID Auto
|PMID=25035659
|Title=Association between hsa-miR-34b/c rs4938723 T &gt; C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls
}}

{{PMID Auto
|PMID=25190020
|Title=Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population
}}

{{PMID Auto
|PMID=25190019
|Title=The genetic association between pri-miR-34b/c polymorphism (rs4938723 T &gt; C) and susceptibility to cancers: evidence from published studies
}}

{{PMID Auto
|PMID=25201061
|Title=Pri-miR-34b/c rs4938723 TC heterozygote is associated with increased cancer risks: evidence from published data
}}

{{PMID Auto
|PMID=25227823
|Title=Association between a Polymorphism in miR-34b/c and Susceptibility to Cancer - a Meta-analysis
}}
{{on chip | Illumina Human 1M}}